Holen Sie sich die Stockscreener-App
3.91
6.68%
-0.28
Handel nachbörslich:
3.85
-0.06
-1.53%
Schlusskurs vom Vortag:
$4.19
Offen:
$4.17
24-Stunden-Volumen:
1.95M
Relative Volume:
0.76
Marktkapitalisierung:
$426.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-209.38M
KGV:
-2.0833
EPS:
-1.8768
Netto-Cashflow:
$-179.81M
1W Leistung:
+1.82%
1M Leistung:
+50.38%
6M Leistung:
+4.83%
1J Leistung:
+23.73%
1-Tages-Spanne:
$3.77
$4.17
1-Wochen-Bereich:
$3.77
$4.33
52-Wochen-Spanne:
$2.53
$5.45
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Firmenname
Rocket Pharmaceuticals Inc
Sektor
Branche
Telefon
646-440-9100
Adresse
350 FIFTH AVENUE, NEW YORK, NY
Compare RCKT vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.91 | 457.52M | 0 | -209.38M | -179.81M | -1.8768 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 126.01B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 70.03B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 56.56B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 40.63B | 742.00K | -1.37B | -1.07B | -7.0731 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-08-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-07-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-30 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-05-28 | Herabstufung | Goldman | Neutral → Sell |
| 2025-05-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-28 | Herabstufung | Jefferies | Buy → Hold |
| 2025-05-28 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | Herabstufung | Needham | Buy → Hold |
| 2025-05-27 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-03-12 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-12-30 | Eingeleitet | Wedbush | Outperform |
| 2024-12-18 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-04-02 | Eingeleitet | Goldman | Neutral |
| 2023-10-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-02-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-11-01 | Eingeleitet | BTIG Research | Buy |
| 2022-07-08 | Eingeleitet | Raymond James | Outperform |
| 2021-10-20 | Fortgesetzt | Cowen | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
| 2021-02-18 | Eingeleitet | Needham | Buy |
| 2020-12-16 | Eingeleitet | UBS | Buy |
| 2020-12-08 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-07-02 | Eingeleitet | JP Morgan | Overweight |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Outperform |
| 2019-11-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-09-26 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-04-23 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-03-15 | Eingeleitet | BofA/Merrill | Buy |
| 2019-02-05 | Eingeleitet | Oppenheimer | Outperform |
| 2018-09-13 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-10 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten
RCKT Stock Dives Despite Gene Therapy Approval — Wall Street Dismisses Sell-Off - Stocktwits
Rocket Pharmaceuticals (RCKT) accounting chief reports 52,576-share RSU stake - Stock Titan
Price to earnings forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKTW - TradingView
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences - AOL.com
Form 144 ROCKET PHARMACEUTICALS For: 7 July By Investing.com - Investing.com India
[144] ROCKET PHARMACEUTICALS, INC. SEC Filing - Stock Titan
Number of shareholders of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKTW - TradingView
Director at Rocket Pharmaceuticals (RCKT) receives RSUs and stock options - Stock Titan
Rocket Pharmaceuticals (RCKT) director receives new RSU and stock option awards - Stock Titan
RCKT Stock Jumps Over 10% Premarket: FDA Approves Its First Gene Therapy For Rare Childhood Immune Disease - Stocktwits
Securities Lawsuit Alert: Rocket Pharmaceuticals, Inc. (RCKT)Contact Levi & Korsinsky Before August 11, 2025 - The National Law Review
Rocket Pharmaceuticals, Inc. Warrant 2023- on Rocket Pharmctc Financial Disclosures & SEC Filings - TradingView
RCKT Q1 2026 Earnings: Slight EPS Miss as Pre-Revenue Biotech Advances PipelineHigh Estimate Range - dars.gov.et
Rocket Pharmaceuticals Appoints Joseph Manhede as Principal Accounting Officer – SEC 8-K Filing June 2026 - Minichart
Rocket Pharmaceuticals (NASDAQ: RCKT) appoints new Principal Accounting Officer - Stock Titan
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) added to Russell Microcap Value Benchmark Index - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) added to Russell 3000E Index - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM: RCKT) added to Russell Microcap Index - marketscreener.com
Rocket Pharmaceuticals, Inc.(NasdaqGM:RCKT) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Join Class Action to Recover Losses from Rocket Pharmaceuticals - The National Law Review
RCKT ALERT: Levi & Korsinsky Files Securities Fraud Class Action - The National Law Review
Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi - The National Law Review
Investors Urged to Contact Levi & Korsinsky for Information Befor - The National Law Review
Rocket Pharmaceuticals, Inc. (RCKT) LawsuitInvestors Urged to Contact Levi & Korsinsky Before August 11, 2025 - The National Law Review
TNXP Stock Dives For Four Straight Sessions — Retail Eyes Drug Pipeline Payoff - Stocktwits
Price to earnings forward of Rocket Pharmaceuticals, Inc. – BOATS:RCKTW - TradingView
Price to sales forward of Rocket Pharmaceuticals, Inc. – BOATS:RCKTW - TradingView
Enterprise value to revenue forward of Rocket Pharmaceuticals, Inc. – BOATS:RCKTW - TradingView
Rocket Pharma updates cash position after selling priority review voucher - MSN
Price to sales forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView
Rocket Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:RCKT) - TradingView
Rocket Pharmaceuticals, Inc. Actuals & Estimates (HAM:9IP1) - TradingView
Rocket Pharmaceuticals, Inc. Actuals & Estimates (TRADEGATE:9IP1) - TradingView
Price to sales forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView
RCKT Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBITDA forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView
Is Rocket Pharmaceuticals, Inc. (RCKT) Poised for Recovery After Key Gene Therapy Program Milestone? - Insider Monkey
Price to book forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView
Price to earnings forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView
Enterprise value to EBIT forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView
Enterprise value to revenue forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT - TradingView
Price to book forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView
Enterprise value to revenue forward of Rocket Pharmaceuticals, Inc. – TRADEGATE:9IP1 - TradingView
Rocket Pharmaceuticals Inc (RCKT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Rocket Pharmaceuticals Inc (RCKT) Institutional Confidence - TradingKey
ROCKET PHARMACEUTICALS INC (RCKT) Stock Chart - ChartMill
Rocket Pharmaceuticals analyst consensus stays supportive, shares trade near recent lows - AD HOC NEWS
Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):